Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13817
Abstract: Autotaxin (ATX) promotes myocardial inflammation, fibrosis, and the subsequent cardiac remodelling through lysophosphatidic acid production. However, the prognostic impact of serum ATX in non‐ischaemic dilated cardiomyopathy (NIDCM) has not been clarified. We investigated the prognostic… read more here.
Keywords: ischaemic dilated; dilated cardiomyopathy; serum autotaxin; non ischaemic ... See more keywords
Transient versus persistent improved ejection fraction in non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2512
Abstract: The recent definition of heart failure with improved ejection fraction outlined the importance of the longitudinal assessment of left ventricular ejection fraction (LVEF). However, long‐term progression and outcomes of this subgroup are poorly explored. We… read more here.
Keywords: ischaemic dilated; improved ejection; non ischaemic; ejection ... See more keywords
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2514
Abstract: Genotype and left ventricular scar on cardiac magnetic resonance (CMR) are increasingly recognized as risk markers for adverse outcomes in non‐ischaemic dilated cardiomyopathy (DCM). We investigated the combined influence of genotype and late gadolinium enhancement… read more here.
Keywords: ischaemic dilated; non ischaemic; late gadolinium; genotype ... See more keywords
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2019 at "Current Cardiology Reports"
DOI: 10.1007/s11886-019-1236-3
Abstract: Non-ischaemic dilated cardiomyopathy (DCM) occurs in 1 in 2500 individuals in the general population and is associated with considerable morbidity and mortality. Studies involving large numbers of unselected DCM patients have led to consensus guidelines… read more here.
Keywords: risk; ischaemic dilated; risk stratification; scd ... See more keywords
Relationship between serum chloride and prognosis in non-ischaemic dilated cardiomyopathy: a large retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-067061
Abstract: Objectives Serum chloride has a unique homeostatic role in modulating neurohormonal pathways. Some studies have reported that hypochloremia has potential prognostic value in cardiovascular diseases; thus, we aimed to investigate the association of baseline serum… read more here.
Keywords: ischaemic dilated; non ischaemic; serum chloride; study ... See more keywords
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction
Sign Up to like & getrecommendations! Published in 2020 at "Heart"
DOI: 10.1136/heartjnl-2019-315942
Abstract: Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as a result of evidence-based pharmacological and non-pharmacological therapeutic strategies. Nevertheless, the… read more here.
Keywords: risk; ischaemic dilated; risk stratification; arrhythmic risk ... See more keywords